Development of a Mindfulness-Based Smartphone Application for BMT Caregivers

Part of paid clinical trials in Tampa, Florida.

Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Study ID
NCT07352943
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Caregivers of Hematopoietic Stem Cell Transplant (HCT) Patients

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • App — BEHAVIORAL
    A smartphone-delivered mindfulness program providing daily modules, guided meditations, brief strategies, and reflection prompts designed to reduce caregiver burden and distress.

Study Details

This pilot study evaluates the feasibility, acceptability, usability, and engagement of a smartphone-delivered mindfulness intervention for caregivers of hematopoietic stem cell transplant (HCT) patients. Thirty caregivers will use the app for six weeks beginning the week prior to the patient's transplant. Participants will complete baseline and end-of-treatment surveys and a brief qualitative interview.

Key Dates

Start date
Aug 31, 2026
Status verified
Jan 2026
Primary completion
Dec 31, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
30 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: App
    Participants receive access to the smartphone application, a 6-week mindfulness-based behavioral intervention adapted from the FOCUS program. Caregivers begin using the app the week prior to the patient's hematopoietic stem cell transplant and continue through six weeks of daily modules that include audio meditations, videos, text-based content, and reflection exercises.

Primary Outcome Measure

Feasibility: Recruitment Rate [ Time Frame: During the enrollment period (anticipated 6-8 months) ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Moffitt Cancer CenterTampaFlorida33612
Christine Vinci, PhD (PRINCIPAL_INVESTIGATOR)
Joseph Pidala, MD, PhD (SUB_INVESTIGATOR)
Steve Sutton, PhD (SUB_INVESTIGATOR)

Find similar trials in Tampa, FL

By research site
Moffitt Cancer Center· Tampa, FL